• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

Sickle Cell Disease (SCD)
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for SCD trials.

DOWNLOAD BROCHURE GET IN TOUCH

Effective solutions for advancing Sickle Cell Disease research

When it was first described more than 100 years ago, sickle cell disease (SCD) remains an area with limited therapeutic options. Your SCD research program represents hope to millions of patients living with the effects of this disease. That's why we tailored Signant SmartSignals solutions to address specific research challenges so you can deliver new and better treatment options.

Sickle Cell-1

Why Signant Health

  • Simplify Site-Based PROs
  • Reduce Participant Burdens
  • Optimize the SCD Patient Diary
  • Gain Expert Guidance
  • Expand the Reach
  • Digitalize the Process
  • Simplify Site-Based PROs

    Simplify Site-Based PROs

    Your sickle cell disease research protocol likely includes several patient-reported outcome assessments for safety and efficacy measures. Signant's eCOA solution, supported by a project team experienced in this chronic condition, helps simplify site-based PRO assessment administration while improving the quality and reliability of endpoint data.
     
     
     

  • Reduce Participant Burdens

    Reduce Participant Burdens

    SCD pain crises can make everyday tasks difficult for patients. Simplify the clinical trial participation experience with engagement features within our eCOA platform that help inform and encourage participants. Plus, study teams can leverage Telemedicine to reduce unnecessary travel.
     
     

  • Optimize the SCD Patient Diary

    Optimize the SCD Patient Diary

    Gather complete, accurate, and timely data from participants - our team of technical and eCOA science specialists will help you design a clinically meaningful diary and implement it on provisioned or BYOD devices. Pair with our engagement solution to ensure participants provide timely entries.
     

  • Gain Expert Guidance

    Gain Expert Guidance

    From consulting on outcome measure selection to customized participant diary design, Signant's in-house experts will help you navigate common SCD research challenges from study launch to closeout. Talk through your protocol with our experienced clinical science and medicine experts.
     
     
     

  • Expand the Reach

    Expand the Reach

    Meet enrollment goals by conducting your research in more countries, enabled by proven technologies. With Signant's end-to-end solutions, you can obtain informed consent, enroll and randomize participants, and collect COA data remotely. Plus, our secure Telemedicine platform helps study teams and participants connect when site visits are not required.
     
     

  • Digitalize the Process

    Digitalize the Process

    Any of our clinical research technology solutions and services can be used individually, but when you combine them, your study will be optimized from end-to-end to deliver accurate endpoint data.
     
     

Comprehensive Hematology experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our Sickle Cell Disease trial resources
SOLUTION BROCHURE

Sickle Cell Disease Trial Solutions Overview


GET INSIGHTS
VIDEO

Sickle Cell Disease Trial Solutions


WATCH [2 MIN]
SOLUTION

Patient Engagement 


 
LEARN MORE

eClinical solutions for Sickle Cell Disease trials

Ready to learn more?

Discover how Signant can support your current or upcoming sickle cell disease trials. 

DOWNLOAD BROCHURE GET STARTED